Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2009 (2009), Article ID 257403, 10 pages
http://dx.doi.org/10.4061/2009/257403
Research Article

Evaluation of BACE1 Silencing in Cellular Models

1Department of Bioorganic Chemistry, Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland
2Organ Development Research Laboratory, National Institute of Advanced Industrial Science and Technology (AIST), Central 4, 1-1-1 Higashi, Tsukuba Science City, 305-8562 Ibaraki, Japan

Received 6 March 2009; Revised 1 June 2009; Accepted 11 June 2009

Academic Editor: Brian Austen

Copyright © 2009 Malgorzata Sierant et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Goate, M.-C. Chartier-Harlin, M. Mullan et al., “Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease,” Nature, vol. 349, no. 6311, pp. 704–706, 1991. View at Publisher · View at Google Scholar
  2. G. D. Schellenberg, T. D. Bird, E. M. Wijsman et al., “Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14,” Science, vol. 258, no. 5082, pp. 668–671, 1992. View at Google Scholar
  3. E. Levy-Lahad, W. Wasco, P. Poorkaj et al., “Candidate gene for the chromosome 1 familial Alzheimer's disease locus,” Science, vol. 269, no. 5226, pp. 973–977, 1995. View at Google Scholar
  4. I. Grundke-Iqbal, K. Iqbal, M. Quinlan, Y. C. Tung, M. S. Zaidi, and H. M. Wisniewski, “Microtubule-associated protein tau. A component of Alzheimer paired helical filaments,” The Journal of Biological Chemistry, vol. 261, no. 13, pp. 6084–6089, 1986. View at Google Scholar
  5. I. Grundke-Iqbal, K. Iqbal, Y.-C. Tung, M. Quinlan, H. M. Wisniewski, and L. I. Binder, “Abnormal phosphorylation of the microtubule-associated protein τ (τ) in Alzheimer cytoskeletal pathology,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 13, pp. 4913–4917, 1986. View at Google Scholar
  6. Y. Ohyagi and T. Tabira, “Intracellular amyloid beta-protein and its associated molecules in the pathogenesis of Alzheimer's disease,” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 10, pp. 1075–1080, 2006. View at Google Scholar
  7. D. L. Sparks, J. C. Hunsaker III, S. W. Scheff, R. J. Kryscio, J. L. Henson, and W. R. Markesbery, “Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease,” Neurobiology of Aging, vol. 11, no. 6, pp. 601–607, 1990. View at Publisher · View at Google Scholar
  8. J. Nunan and D. H. Small, “Proteolytic processing of the amyloid-β protein precursor of Alzheimer's disease,” Essays in Biochemistry, vol. 38, pp. 37–49, 2002. View at Google Scholar
  9. D. J. Selkoe, “Amyloid β-peptide is produced by cultured cells during normal metabolism: a reprise,” Journal of Alzheimer's Disease, vol. 9, supplement 3, pp. 163–168, 2006. View at Google Scholar
  10. Y.-H. Kuan, T. Gruebl, P. Soba et al., “PAT1a modulates intracellular transport and processing of amyloid precursor protein (APP), APLP1, and APLP2,” The Journal of Biological Chemistry, vol. 281, no. 52, pp. 40114–40123, 2006. View at Publisher · View at Google Scholar
  11. O. Berezovska, A. Lleo, L. D. Herl et al., “Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein,” Journal of Neuroscience, vol. 25, no. 11, pp. 3009–3017, 2005. View at Publisher · View at Google Scholar
  12. T. E. Golde, D. Dickson, and M. Hutton, “Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease,” Current Alzheimer Research, vol. 3, pp. 421–430, 2006. View at Google Scholar
  13. D. M. Skovronsky, D. B. Moore, M. E. Milla, R. W. Doms, and V. M.-Y. Lee, “Protein kinase C-dependent α-secretase competes with β-secretase for cleavage of amyloid-β precursor protein in the trans-Golgi network,” The Journal of Biological Chemistry, vol. 275, no. 4, pp. 2568–2575, 2000. View at Publisher · View at Google Scholar
  14. R. Vassar, “BACE1: the β-secreiase enzyme in Alzheimer's disease,” Journal of Molecular Neuroscience, vol. 23, no. 1-2, pp. 105–113, 2004. View at Publisher · View at Google Scholar
  15. S. L. Cole and R. Vassar, “The role of amyloid precursor protein processing by BACE1, the β-secretase, in Alzheimer disease pathophysiology,” The Journal of Biological Chemistry, vol. 283, no. 44, pp. 29621–29625, 2008. View at Publisher · View at Google Scholar
  16. A. Fire, S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver, and C. C. Mello, “Potent and specific genetic interference by double-stranded RNA in Caenorhabitis elegans,” Nature, vol. 391, pp. 806–811, 1998. View at Google Scholar
  17. M. K. Montgomery, S. Xu, and A. Fire, “RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabitis elegans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, pp. 15502–15507, 1998. View at Google Scholar
  18. G. S. Ralph, N. D. Mazarakis, and M. Azzouz, “Therapeutic gene silencing in neurological disorders, using interfering RNA,” Journal of Molecular Medicine, vol. 83, no. 6, pp. 413–419, 2005. View at Publisher · View at Google Scholar
  19. H. Xia, Q. Mao, S. L. Eliason et al., “RNAi suppresses polyglutamine-induced neurodegeneration in a model ofspinocerebellar ataxia,” Nature Medicine, vol. 10, no. 8, pp. 816–820, 2004. View at Google Scholar
  20. S. Q. Harper, P. D. Staber, X. He et al., “RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 16, pp. 5820–5825, 2005. View at Publisher · View at Google Scholar
  21. B. Nawrot, S. Antoszczyk, M. Maszewska et al., “Efficient inhibition of beta-secretase (BACE) gene expression in HEK293T cells by tRNAVal/CTE-driven hammerhead ribozymes,” European Journal of Biochemistry, vol. 270, pp. 3962–3970, 2003. View at Google Scholar
  22. P. Gonzalez-Alegre, “Therapeutic RNA interference for neurodegenerative diseases: from promise to progress,” Pharmacology and Therapeutics, vol. 114, no. 1, pp. 34–55, 2007. View at Publisher · View at Google Scholar
  23. A. Orlacchio, G. Bernardi, A. Orlacchio, and S. Martino, “RNA interference as a tool for Alzheimer's disease therapy,” Mini-Reviews in Medicinal Chemistry, vol. 7, no. 11, pp. 1166–1176, 2007. View at Publisher · View at Google Scholar
  24. O. Singer, R. A. Marr, E. Rockenstein et al., “Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model,” Nature Neuroscience, vol. 8, no. 10, pp. 1343–1349, 2005. View at Publisher · View at Google Scholar
  25. S.-C. Kao, A. M. Krichevsky, K. S. Kosik, and L.-H. Tsai, “BACE1 suppression by RNA interference in primary cortical neurons,” The Journal of Biological Chemistry, vol. 279, no. 3, pp. 1942–1949, 2004. View at Publisher · View at Google Scholar
  26. M. H. Caruthers, “Gene synthesis machines: DNA chemistry and its uses,” Science, vol. 230, no. 4723, pp. 281–285, 1985. View at Google Scholar
  27. M. Sano, Y. Kato, H. Akashi, M. Miyagishi, and K. Taira, “Novel methods for expressing RNA interference in human cells,” Methods in Enzymology, vol. 392, pp. 97–112, 2005. View at Publisher · View at Google Scholar
  28. T. R. Brummelkamp, R. Bernards, and R. Agami, “A system for stable expression of short interfering RNAs in mammalian cells,” Science, vol. 296, no. 5567, pp. 550–553, 2002. View at Publisher · View at Google Scholar
  29. H. Qing, W. Zhou, M. A. Christensen, X. Sun, Y. Tong, and W. Song, “Degradation of BACE by the ubiquitin-proteasome pathway,” The FASEB Journal, vol. 18, no. 13, pp. 1571–1573, 2004. View at Publisher · View at Google Scholar
  30. K. Sipa, E. Sochacka, J. Kazmierczak-Baranska et al., “Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA,” RNA, vol. 13, no. 8, pp. 1301–1316, 2007. View at Publisher · View at Google Scholar
  31. G. Tiscornia, O. Singer, M. Ikawa, and I. M. Verma, “A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 4, pp. 1844–1848, 2003. View at Publisher · View at Google Scholar
  32. H. Miyoshi, U. Blömer, M. Takahashi, F. H. Gage, and I. M. Verma, “Development of a self-inactivating lentivirus vector,” Journal of Virology, vol. 72, no. 10, pp. 8150–5157, 1998. View at Google Scholar
  33. R. A. Marr, H. Guan, E. Rockenstein et al., “Neprilysin regulates amyloid ß peptide levels,” Journal of Molecular Neuroscience, vol. 22, no. 1-2, pp. 5–11, 2004. View at Publisher · View at Google Scholar
  34. L. Naldini, U. Blömer, P. Gallay et al., “In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector,” Science, vol. 272, no. 5259, pp. 263–267, 1996. View at Google Scholar
  35. F. H. Gage, P. W. Coates, T. D. Palmer et al., “Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 25, pp. 11879–11883, 1995. View at Publisher · View at Google Scholar
  36. M. Miyagishi and K. Taira, “Strategies for generation of an siRNA expression library directed against the human genome,” Oligonucleotides, vol. 13, no. 5, pp. 325–333, 2003. View at Publisher · View at Google Scholar
  37. M. Miyagishi, S. Matsumoto, and K. Taira, “Generation of an shRNAi expression library against the whole human transcripts,” Virus Research, vol. 102, no. 1, pp. 117–124, 2004. View at Publisher · View at Google Scholar
  38. http://cluster-1.mpi-cbg.de/Deqor/deqor.html.
  39. http://www.dharmacon.com/sidesign/default.aspx.
  40. Y.-L. Chiu and T. M. Rana, “RNAi in human cells: basic structural and functional features of small interfering RNA,” Molecular Cell, vol. 10, no. 3, pp. 549–561, 2002. View at Publisher · View at Google Scholar
  41. R. Yan, P. Han, H. Miao, P. Greengard, and H. Xu, “The transmembrane domain of the Alzheimer's β-secretase (BACE1) determines its late Golgi localization and access to β-amyloid precursor protein (APP) substrate,” The Journal of Biological Chemistry, vol. 276, no. 39, pp. 36788–36796, 2001. View at Publisher · View at Google Scholar
  42. Y. Zeng and B. R. Cullen, “Structural requirements for pre-microRNA binding and nuclear export by Exportin 5,” Nucleic Acids Research, vol. 32, no. 16, pp. 4776–4785, 2004. View at Publisher · View at Google Scholar
  43. E. H. Koo and R. Kopan, “Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration,” Nature Medicine, vol. 10, supplement, pp. S26–S33, 2004. View at Publisher · View at Google Scholar
  44. J. Shen, R. T. Bronson, D. F. Chen, W. Xia, D. J. Selkoe, and S. Tonegawa, “Skeletal and CNS defects in Presenilin-1-deficient mice,” Cell, vol. 89, no. 4, pp. 629–639, 1997. View at Google Scholar
  45. R. Yan, M. J. Bienkowski, M. E. Shuck et al., “Membraneanchored aspartyl protease with Alzheimer's disease beta-secretase activity,” Nature, vol. 402, pp. 533–537, 1999. View at Google Scholar
  46. G. Basi, N. Frigon, R. Barbour et al., “Antagonistic effects of ß-site amyloid precursor protein-cleaving enzymes 1 and 2 ß-amyloid peptide production in cells,” The Journal of Biological Chemistry, vol. 278, no. 34, pp. 31512–31520, 2003. View at Publisher · View at Google Scholar
  47. B. Nawrot, “Targeting BACE with small inhibitory nucleic acids—a future for Alzheimer's disease therapy?” Acta Biochimica Polonica, vol. 51, no. 2, pp. 431–444, 2004. View at Google Scholar
  48. M. Sierant, K. Kubiak, J. Kazmierczak-Baranska et al., “RNA interference in silencing of genes of Alzheimer's disease in cellular and rat brain models,” Nucleic Acids Symposium Series, vol. 52, pp. 41–42, 2008. View at Google Scholar
  49. A. K. Langer, H. F. Poon, G. Münch, B. C. Lynn, T. Arendt, and D. A. Butterfield, “Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells,” Neurotoxicity Research, vol. 9, no. 4, pp. 255–268, 2006. View at Publisher · View at Google Scholar
  50. Y. Sakai, V. Khajoee, Y. Ogawa, K. Kusuhara, Y. Katayama, and T. Hara, “A novel transfection method for mammalian cells using gas plasma,” Journal of Biotechnology, vol. 121, no. 3, pp. 299–308, 2006. View at Publisher · View at Google Scholar
  51. D. S. Schwarz, H. Ding, L. Kennington et al., “Designing siRNA that distinguish between genes that differ by a single nucleotide,” PLoS Genetics, vol. 2, no. 9, article e140, 2006. View at Google Scholar
  52. A. L. Jackson, S. R. Bartz, J. Schelter et al., “Expression profiling reveals off-target gene regulation by RNAi,” Nature Biotechnology, vol. 21, no. 6, pp. 635–637, 2003. View at Publisher · View at Google Scholar
  53. E. Anderson, Q. Boese, A. Khvorova, and J. Karpilow, “Identifying siRNA-induced off-targets by microarray analysis,” Methods in Molecular Biology, vol. 442, pp. 45–63, 2008. View at Publisher · View at Google Scholar
  54. C. J. Schoenherr, A. J. Paquette, and D. J. Anderson, “Identification of potential target genes for the neuron-restrictive silencer factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 18, pp. 9881–9886, 1996. View at Publisher · View at Google Scholar
  55. N. Mori and H. Morii, “SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging,” Journal of Neuroscience Research, vol. 70, no. 3, pp. 264–273, 2002. View at Publisher · View at Google Scholar